Chloramphenicolpalmitat

Chloramphenicol palmitate Struktur
530-43-8
CAS-Nr.
530-43-8
Bezeichnung:
Chloramphenicolpalmitat
Englisch Name:
Chloramphenicol palmitate
Synonyma:
cap-p;detreopal;Chloropal;Chlorambon;cap-palmitate;Clorolifarina;chloromycetinpalmitate;CHLORAMPHENICOL PALMITATE;CHLORAMPHENICAL PALMITATE;Chloramphenicol Impurity 2
CBNumber:
CB0437291
Summenformel:
C27H42Cl2N2O6
Molgewicht:
561.54
MOL-Datei:
530-43-8.mol

Chloramphenicolpalmitat Eigenschaften

Schmelzpunkt:
90 C
alpha 
D26 +24.6° (c = 5 in ethanol)
Siedepunkt:
691.6±55.0 °C(Predicted)
Dichte
1.2354 (rough estimate)
Brechungsindex
1.7350 (estimate)
storage temp. 
Store at RT.
Löslichkeit
DMSO (Slightly), Ethanol (Sparingly), Ethyl Acetate (Slightly)
pka
10.69±0.46(Predicted)
Farbe
White to Off-White
Wasserlöslichkeit
8.423ug/L(25 ºC)
maximale Wellenlänge (λmax)
271nm(EtOH)(lit.)
Merck 
14,2077
BRN 
2826438
Stabilität:
Hygroscopic
CAS Datenbank
530-43-8(CAS DataBase Reference)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 40-36/37/38-20/21/22
S-Sätze: 36/37-36-26
WGK Germany  3
RTECS-Nr. RT4735000
HS Code  29414000
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H351 Kann vermutlich Krebs verursachen. Karzinogenität Kategorie 2 Warnung P201, P202, P281, P308+P313, P405,P501
Sicherheit
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

Chloramphenicolpalmitat Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R40:Verdacht auf krebserzeugende Wirkung.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.

S-Sätze Betriebsanweisung:

S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.

Beschreibung

Chloramphenicol palmitate is an orally bioavailable ester prodrug form of the antibiotic chloramphenicol. It is hydrolyzed in the small intestine to release chloramphenicol. Formulations containing chloramphenicol palmitate were previously used in the treatment of severe bacterial infections.

Chemische Eigenschaften

white crystals

Verwenden

Chloramphenicol palmitate is prepared by acylation of chloramphenicol with palmitic acid. Although chloramphenicol palmitate is a more hydrophobic drug which should enhance bioavailability, the primary advantage of the ester is to mask the taste of chloramphenicol in oral formulations. Chloramphenicol palmitate is significantly less active than chloramphenicol but acts as a prodrug, being readily hydrolysed by acid and esterase in the gut to release chloramphenicol.

Application

Chloramphenicol palmitate was synthesized by Parke Davis Co. in 1952. It has a much less bitter taste than chloramphenicol and is suitable for oral administration, especially for children. The palmitate shows a higher serum level after oral administration than chloramphenicol does and acts the same as chloramphenicol in vivo.

Allgemeine Beschreibung

Chloramphenicol palmitate is the palmitic acid ester ofchloramphenicol. It is a tasteless prodrug of chloramphenicolintended for pediatric use. The ester must hydrolyze invivo following oral absorption to provide the active form.Erratic serum levels were associated with early formulationsof the palmitate, but the manufacturer claims that thebioavailability of the current preparation is comparable tothat of chloramphenicol itself.

Sicherheitsprofil

Moderately toxic by oral route. An experimental teratogen. Other experimental reproductive effects. An antibiotic. When heated to decomposition it emits very toxic fumes of NOx and Cl-. See also other chloramphenicol entries.

läuterung methode

The palmitate crystallises from *benzene or xylene with m 105-106o and [] D –39.5o (c 2, Et2O), max 267.3nm. [Edgerton et al. J Am Chem Soc 77 27 1955, Beilstein 13 IV 2753.]

Chloramphenicolpalmitat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Chloramphenicolpalmitat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 236)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49390 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Shaanxi Dideu Medichem Co. Ltd
+86-29-87569266 15319487004
1015@dideu.com China 2263 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58
AFINE CHEMICALS LIMITED
0571-85134551
info@afinechem.com CHINA 15377 58
BOC Sciences
+16314854226
inquiry@bocsci.com United States 19743 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739
info@dycnchem.com CHINA 52867 58
Alfa Chemistry
+1-5166625404
Info@alfa-chemistry.com United States 21317 58

530-43-8(Chloramphenicolpalmitat)Verwandte Suche:


  • CHLORAMPHENICOL ALPHA-PALMITATE
  • CHLORAMPHENICOL PALMITATE
  • alpha-esterwithd-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-palmiticaci
  • cap-p
  • cap-palmitate
  • chloramphenicolmonopalmitate
  • CHLORAMPHENICAL PALMITATE
  • CHLOROAMPHENICOL PALMITATE VETRANAL,250
  • chloramphenicolpalmitate(ester)
  • chloromycetinpalmitate
  • Clorolifarina
  • detreopal
  • ChloramphenicolPalmitateChloramphenicolPalmitateBp
  • CHLORAMPHENICOLPALMITATE,BP
  • CHLORAMPHENICOLPALMITATE,USP
  • Acetamide, 2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl]-, α-palmitate, D-threo- (8CI)
  • Chlorambon
  • Chloramphenicol monopalmitate (ester)
  • Chloropal
  • D-(-)-Chloramphenicol palmitate
  • Hexadecanoic acid, (2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester
  • Hexadecanoic acid, 2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester, [R-(R*,R*)]-
  • Palmitic acid, ester with chloramphenicol (6CI)
  • Palmitic acid, α-ester with D-threo-(-)-2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl]acetamide (8CI)
  • (2R,3R)-2-[(2,2-Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate
  • Palmitic acid chloramphenicol
  • Chloramphenicol Palmitate (200 mg)
  • Chloramphenicol Palmitate Nonpolymorph A (200 mg)
  • Chloramphenicol Palmitat e Polymorph A (100 mg)
  • Chloramphenicol palmitate polymorph A
  • Chloramphenicol palmitate nonpolymorph A
  • ChloraMphenicol 3-palMitate
  • hexadecanoic acid [(2R,3R)-2-[(2,2-dichloro-1-oxoethyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester
  • Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester
  • Chloramphenicol Impurity 2
  • 2,2-Dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)-2-propyl]acetamide Palmitate
  • D-(-)-threo-2-Dichloroacetamido-1-(4-nitrophenyl)-1,3-propanediol Palmitate
  • Chloramphenicol Palmitate Nonpolymorph A (1107401)
  • Chloramphenicol Palmitate Polymorph A (1107503)
  • Chloramphenicol Palmitate (1107300)
  • 530-43-8
  • C27H42Cl2N2O6
  • CHLOROPAL
  • BacteriostaticAlphabetic
  • CHAntibiotics
  • Standards for SupelMIPTM SPE
  • Antibiotics
  • C
  • Chemical Structure
  • Chromatography
  • OthersAnalytical Standards
  • Principle
Copyright 2019 © ChemicalBook. All rights reserved